The IPSS-R has prognostic impact in untreated patients with MDS del(5q).
Kaivers J, Lauseker M, Hildebrandt B, Fenaux P, Pfeilstöcker M, Valent P, Platzbecker U, Latagliata R, Oliva EN, Xicoy B, Götze K, Ganster C, Haase D, Bug G, Kündgen A, Gattermann N, Haas R, Germing U.
Kaivers J, et al. Among authors: valent p.
Leuk Res. 2018 Sep;72:27-33. doi: 10.1016/j.leukres.2018.07.019. Epub 2018 Jul 23.
Leuk Res. 2018.
PMID: 30075323
Clinical Trial.